Web-Based Filial Therapy In Pediatric Cancer
Web Based
A Randomized Controlled Trial Examining the Effect of a Web-Based Filial Therapy Program on Parental Role Perception Among Parents of Children With Cancer
1 other identifier
interventional
60
1 country
1
Brief Summary
This study examines the effect of a web-based filial therapy program on parental role perception among parents of children diagnosed with cancer. Pediatric cancer not only affects the physical health of the child but also disrupts the emotional and relational dynamics within the family. Due to hospitalization, infection risk, and treatment demands, children may have limited opportunities for play, which is essential for emotional expression and development. At the same time, parents may become primarily focused on the child's medical care and may experience difficulties in maintaining their parenting role. Filial therapy is an approach that helps parents support their child's emotional needs through structured play. In this study, a 5-week web-based filial therapy program was developed to provide accessible training for parents without requiring separation from their child. Parents learned basic therapeutic play skills and applied them in their daily interactions with their child. The study was conducted as a randomized controlled trial with 60 parents, divided into intervention and control groups. The results aim to determine whether the program improves parents' perceptions of their parenting role. This research may contribute to the development of accessible psychosocial interventions that support both children and parents in the context of pediatric cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 11, 2025
CompletedFirst Submitted
Initial submission to the registry
March 21, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedMarch 30, 2026
March 1, 2026
1.4 years
March 21, 2026
March 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Self-Perception of Parental Role Scale (SPPRS)
Self-Perception of Parental Role Scale (SPPRS) total score. The scale consists of 18 items, with total scores ranging from 18 to 72. Higher scores indicate a more positive perception of the parental role. Assessments will be conducted at baseline and after the 5-week intervention period.
Pre-test (baseline) and post-test (5 weeks)
Study Arms (2)
Web-Based Filial Therapy
EXPERIMENTALParticipants in this group received a 5-week web-based filial therapy program, including video-based training, structured parent-child play sessions, and individualized feedback.
Control Group
NO INTERVENTIONParticipants in this group received no intervention during the study period.
Interventions
The intervention consisted of a 5-week web-based filial therapy program designed for parents of children diagnosed with cancer. The program included pre-recorded video sessions providing structured training in core filial therapy skills, such as empathic listening, child-led play, emotional reflection, and therapeutic limit setting. Parents were instructed to apply these skills during structured play sessions with their children in their natural environment. To support adherence and intervention fidelity, participants submitted video recordings of their play sessions through the web platform and received individualized feedback from the researcher. The program also included reminder messages and an integrated messaging system to facilitate communication between participants and the researcher.
Eligibility Criteria
You may qualify if:
- Parent of a child diagnosed with cancer
- Child under 12 years of age
- Living with the child
- Literate
- No diagnosed psychiatric disorder
- Access to a computer and internet connection
- Active use of digital communication tools (internet, phone, or email)
- Willing to participate voluntarily and provide informed consent
You may not qualify if:
- Diagnosed psychiatric disorder
- Inability to use digital tools
- Failure to complete the intervention program
- Withdrawal from the study during the intervention period
- Experiencing child loss during the study
- Having a child older than 12 years diagnosed with cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ondokuz Mayis Univetsity Hospital
Atakent, Samsun, 55200, Turkey (Türkiye)
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
serap GULEC Keskin, Associate Professor
Ondokuz Mayıs University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 21, 2026
First Posted
March 27, 2026
Study Start
September 25, 2023
Primary Completion
January 30, 2025
Study Completion
July 11, 2025
Last Updated
March 30, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to ethical and privacy considerations. The dataset contains sensitive information from parents of children diagnosed with cancer, and participants did not provide consent for public data sharing.